Telehealth

Virtual Care Telehealth Services Weight Loss Prescription Medications Medicare Pharmaceuticals Weight Loss Drugs Mental Health Regulatory Compliance Women's Health Services

Hims & Hers Shares Jump as Obesity Treatment Push Wins Fresh Investor Support

Investor interest was driven by rising demand for Wegovy and Ozempic, the appointment of a new chief medical officer, plus a broad market rally.

Hims & Hers Lifts Sales Outlook as GLP‑1 Pivot Squeezes Profits

Hims & Hers Shares Slide After Surprise Q1 Loss as Weight‑Loss Pivot Hits Margins

UCLA Study Finds Telehealth Boom Did Not Raise Visits or Costs

Bank of America Cuts Hims & Hers Target as GLP‑1 Pivot Squeezes Margins

UHS to Acquire Talkspace in $835 Million Deal

FDA Warns 30 Telehealth Firms Over Misleading Ads for Compounded GLP-1 Weight-Loss Drugs

Hims & Hers to Acquire Australia’s Eucalyptus for Up to $1.15 Billion

Lilly, Novo Nordisk Reject Mangoceuticals’ Claimed GLP-1 Partnership as Shares Sink

Text-Based Psychotherapy Matches Video Sessions in Large Trial

HHS Grants VSee FedRAMP High ATO as Shares Jump on Government Access

Hims & Hers Shares Drop on Q2 Revenue Miss Despite Profit Beat

Teladoc Stock Jumps After Citron Labels It a ‘Coiled Spring’

Hims & Hers to Acquire Zava, Adding 1.3M Customers in Europe

Hims & Hers Reaffirms Growth Targets After Record Q1 Performance and Convertible Note Offering

Wearable Skin Patch Tracks Genuine Emotions with Breakthrough Accuracy

U.S. Abortion Numbers Show Slight Increase as Telehealth Gains Traction

Eli Lilly Sues Strive and Empower Over Unapproved Tirzepatide Products

Menopause’s Impact on Work, Health, and Awareness Gains Attention

Spike in Birth Control and Abortion Pill Demand Post-Trump Re-election